Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / FOLH1B

FOLH1B

Basics

Aliases:
This biomarker is also known as:
  • folate hydrolase pseudogene,
  • putative folate hydrolase 1B,
  • PSMA-LIKE,
  • EC 3.4.-.-,
  • Q9HBA9,
  • cell growth-inhibiting gene 26 protein,
  • PSMAL,
  • N-acetylated-alpha-linked-acidic dipeptidase,
  • PSM,
  • prostate-specific membrane antigen-like protein,
  • Prostate-specific membrane antigen-like protein,
  • glutamate carboxypeptidase III,
  • Cell growth-inhibiting gene 26 protein,
  • Putative folate hydrolase 1B,
  • folate hydrolase 1B,
  • FOLHP,
  • folate hydrolase 2,
  • FOLH2,
  • GCP3,
  • GCPIII,
  • putative N-acetylated-alpha-linked acidic dipeptidase,
  • NAALADase,

View in BioMuta

Description…

FOLH1B, or PSMAL, is a cytoplasmic protein. It has been found in the kidney and liver, and has not been detected in the prostate. GO annotations related to this gene include metallopeptidase activity and dipeptidase activity.

Attributes

QA State: Curated
Type: Protein
Short Name:

Datasets

There are no datasets associated with this biomarker.

Organs

The following organs have data associated with this biomarker…

Ovary

Attributes

Phase: One
QA State: Under Review

Overview

No additional ovarian data available.

Performance Comment

FOLH1B (PSMAL) was one of 50 tumor vasculature-associated genes with transmembrane or secreted protein products identified through expression profiling of ovarian cancer vascular cells. These 50 tumor vascular markers (TVMs) also had low or no expression in normal tissues. FOLH1B (PSMAL) was not in the group of 13 selected for further validation.

Prostate

Attributes

Phase: One
QA State: Under Review

Overview

Performance Comment

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.

Announcement 06/05/2014


Funding Opportunity Available

Both RFAs for Molecular and Cellular Characterization of Screen-Detected Lesions have been published.

RFA-CA-14-010.html

and

RFA-CA-14-011.html